HeRO ® graft clinical manifestations

Understand the HeRO clinical data and results of Graft.
Understand the clinical data and results, because Jeffrey h. Dr Lawson and Shawn m. Gage, PA - C discussed about HeRO Graft of the published data.

Fewer infections:Compared with the catheter, infection rate by 69%1

The remarkable dialysis adequacy:1.7 Kt/V, increased by 16% ~ 32% in comparison with catheter1

High flow rate:Cumulative patency rate is as high as 2% in 871, 2,

Cost savings:Compared with the catheter, save an average of 23% a year3

Clinical outcome

HERO GRAFT
Gage, etc.The joint venture2		 HERO GRAFT
Katzman, etc.The joint venture1		 Catheter literature1 AV grafts literature1
Bacteremia rate
(number of infections / 1000 days)		 0.14 0.70 2.3 0.11
The adequacy of dialysis,
(average KT/V)§		 Do not apply 1.7 1.29-1.46 1.37-1.62
Cumulative patency rate
(1 year)		 91% 72% ǂ 37% 65%
Intervention rate
(every year)
 1.5 2.5 5.8 1.6-2.4

§ note: every 0.1 below the Kt/V, a 7% increase in mortality4And the number of hospitalized increased by 0.05%, a 11% increase in hospitalization days and be in hospital of insurance of medical costs $12 significantly associated with an increased (P < 940).5

ǂ 8.6 months

reference

  1. Katzman has, MD, J Vasc Surg, 2009.
  2. Of the EJVES Gage, 2012.
  3. Dageforde et al., JSR 2012.
  4. The international 2001 Dhingra added, such as kidneys.
  5. 2006 NKF KDOQI guidelines. 4.